Georgia has been recognized as the #1 State for Business for more than 8 consecutive years, and much of that stems from investment in the manufacturing sector. HunterMaclean actively assists clients in the manufacturing/advanced manufacturing industry with expansion and new investment in this key economic area. Our team partners with clients to develop aggressive growth strategies, as well as assist clients in addressing environmental investigations, contracting issues, negotiation of incentives such as tax abatements and grant funds, mergers and acquisitions, and corporate governance.
Representing the majority shareholders in the sale of all of the outstanding stock of a local manufacturing company for approximately $97 million. The purchase price was paid in cash, by the issuance of senior and junior subordinated notes, and by the issuance of restricted stock of the purchaser to certain of the selling shareholders.
Lead counsel in bet-the-company litigation related to the design and construction of a biofuel manufacturing plant.
Represented a Fortune 500 company in the acquisition of two specialty starch businesses and related mills and manufacturing facilities.
Assisted a metal fabricating business based in the Northeast with due diligence and contracting matters related to a plant expansion in north Georgia. This was a development authority transaction that was being structured as a lease with payments in lieu of taxes.
Successful representation of a large manufacturer of industrial goods against alleged OSHA repeat violations claim by procuring a positive resolution on the eve of trial.
Assisted an international manufacturer of building materials in locating a new plant in Georgia, including customary due diligence, documentation related to incentives, and associated real estate matters.
Representing a national manufacturing company in the sale of its stock, which was traded on the New York Stock Exchange, to another publicly traded manufacturing company. This transaction occurred in two parts: first, the acquisition of 50.1% of the outstanding stock of our client and second, the merger of HunterMaclean’s client with and into the purchaser.
Co-authored by attorney Justin Guthrie, this article was published in the Spring 2022 Survey Issue of the American Bar Association’s Tort Trial & Insurance Practice Law Journal. This article discusses noteworthy admiralty…
In a first-of-its-kind lawsuit brought by relatives of opioid addicts against medical supply distributors, a HunterMaclean defense team obtained a full defense verdict for McKesson Corporation after a five-week trial…